[Interaction of L-DOPA and pyridoxine (a review of the literature)].
D000586:Amination; D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D003653:Decarboxylation; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D066298:In Vitro Techniques; D007980:Levodopa / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D008745:Methylation; D008750:Methyldopa / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy; D011485:Protein Binding / Q000187:drug effects; D011736:Pyridoxine / Q000378:metabolism / Q000494:pharmacology*
D002395:Catecholamines; D007980:Levodopa; D008750:Methyldopa; D011736:Pyridoxine; D004298:Dopamine
Vzaimodeĭstvie L-DOFA i piridoksina (obzor literatury).